Document 3244 DOCN M94A3244 TI Acquired specific cytotoxic activity in CD8+ HIV-1IIIB carrier cell clones derived from CD4+CD8+ parental human T cell leukemia cell lines. DT 9412 AU Minowada J; Otani T; Kamiya T; Fujisaki Cell Center, Okayama, Japan. SO Int Conf AIDS. 1994 Aug 7-12;10(1):120 (abstract no. PA0100). Unique Identifier : AIDSLINE ICA10/94369331 AB OBJECTIVE: To determine the functional activity of CD8 positive HIV-1 carrier cell clones. METHOD: A 4-hr two-color flow cytometric cytotoxicity assay was used. The effector/target cell ratio analyzed was in the 0.2-3.0/1 range. RESULTS, DISCUSSION AND CONCLUSION: Seven HIV-1IIIB carrier CD8+ MOLT-4 clones from T-cell leukemia cell line MOLT-4 with a CD4+CD8+ phenotype, and 5 CD8+ HIV-1 carrier cell lines from 3 other CD4+CD8+ leukemia cell lines were used. Of the 7 MOLT-4/HIV clones used, 4 exhibited cytotoxic activity specific to 2 immature T cell lines, HPB-ALL and SUP-T1, of 21 clonal leukemia cell lines tested with T-, B- or myelomonocytic origins. Pretreatment of the cytotoxic, but not the noncytotoxic, clones with PMA augmented this specific cytotoxic activity. Two-color cytotoxicity analysis indicated unidirectional cytotoxicity; (i.e. CD8+-CD4+/CD8+). While no correlation was found between cytotoxicity and 1) persistent infectious virus release, 2) gp120 antigen or 3) p24 antigen expression, CD8 positivity and its enhanced expression in the HIV-carrier clones appear to be associated with specific cytotoxicity. The in vivo target cell counterpart and the specific recognition molecules on the CD8-positive HIV-1 carrier cells remain to be determined. The observation, however, provides evidence for a mechanism underlying the immunodysfunction associated with AIDS pathogenesis. DE Antigens, CD/*IMMUNOLOGY Antigens, CD4/*IMMUNOLOGY Antigens, CD8/*IMMUNOLOGY Cell Line Clone Cells Comparative Study *Cytotoxicity, Immunologic Flow Cytometry/METHODS Human HIV Core Protein p24/ANALYSIS/BIOSYNTHESIS HIV Envelope Protein gp120/ANALYSIS/BIOSYNTHESIS HIV-1/*IMMUNOLOGY/METABOLISM Leukemia, T-Cell Tumor Cells, Cultured MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).